Every Form 4 that Savara Inc. (SVRA) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow SVRA and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SVRA filings page.
Savara Inc reported that Chief Fin. & Operating Officer Robert Matthew Lutz received equity awards on July 15, 2026. He was granted 35,000 restricted stock units that vest in full on July 15, 2028, subject to continued service, and options for 70,000 shares at an exercise price of $5.81 per share, vesting in 16 equal quarterly installments starting July 15, 2026. Following these grants, he directly holds 328,977 shares of common stock and 70,000 stock options.
Savara Inc Chief Financial Officer David L. Lowrance reported a combined option exercise and share sale in Savara common stock. On June 22, 2026, he sold 394,528 shares in an open-market transaction at a weighted average price of $5.6813 per share, with sale prices ranging from $5.54 to $5.78. On the same date, he exercised stock options covering a total of 580,187 shares at exercise prices between $1.11 and $4.45 per share, and 185,659 shares were withheld to satisfy tax obligations. Following these transactions, Lowrance directly owned 536,032 shares of Savara common stock.
Savara Inc Chief Financial Officer David L. Lowrance exercised several stock option grants on March 18, 2026, acquiring a total of 366,747 shares of Common Stock through option exercises at strike prices ranging from $1.11 to $4.45 per share. To cover exercise costs and tax obligations, 116,760 shares of Common Stock were withheld by the issuer in transactions coded as F, which are tax-withholding dispositions rather than open‑market sales. Following these transactions, Lowrance directly owned 536,032 shares of Savara common stock. The derivative transactions reflect routine option exercises tied to grants that vest in quarterly installments, as described in the footnotes.
Savara Inc director Joseph S. McCracken exercised stock options on February 16, 2026 to acquire 1,807 shares of common stock at $1.76 per share. These options, granted at an exercise price of $1.76, had vested in twelve equal quarterly installments beginning on March 15, 2017. After this option exercise, McCracken directly holds 302,644 shares of Savara common stock.
Savara Inc's Chief Financial Officer, David Lowrance, reported two transactions in the company’s common stock. On December 14, 2025, 62,960 shares were disposed of at $6.92 per share, representing shares withheld by Savara to cover tax liabilities from the vesting of previously awarded restricted stock units, leaving him with 318,045 shares owned directly.
On December 16, 2025, he reported a bona fide gift of 32,000 shares to The McCallie School at a reported price of $0.00 per share, after which he directly owned 286,045 shares of Savara common stock. He does not have voting or investment power over the shares held by The McCallie School.
Savara Inc director and chief executive officer Matthew Pauls reported two changes in his common stock holdings. On 12/14/2025, 195,705 shares of common stock were disposed of at $6.92 per share, representing shares withheld by the company to cover tax liabilities arising from the vesting of previously awarded restricted stock units. After this, he held 1,317,045 shares.
On 12/16/2025, he reported a disposition of 128,995 common shares at a price of $0.00, reflecting a transfer to the GP 2024 Trust, U/A dated 12/20/2024, for no consideration. He is not a trustee of the trust and does not retain investment or voting control over those shares, and disclaims beneficial ownership except to the extent of any pecuniary interest. Following this gift, he beneficially owns 1,188,050 Savara common shares directly.
Savara Inc reported an insider equity transaction by its Chief Operating Officer, Robert Lutz. On 12/14/2025, the company withheld 67,760 shares of Savara common stock at $6.92 per share to cover his tax obligations arising from the vesting of previously awarded restricted stock units.
After this tax-related share withholding, Robert Lutz directly beneficially owned 293,977 shares of Savara common stock.
Savara Inc's chief legal officer reported an equity transaction involving company stock. On 12/14/2025, Savara withheld 39,350 shares of common stock at $6.92 per share to satisfy the reporting person's tax liability arising from the vesting of previously awarded restricted stock units. After this tax withholding transaction, the officer beneficially owned 519,232 shares of Savara common stock directly.
Savara Inc chief business officer Anne Erickson reported a tax-related disposition of common stock. On 12/14/2025, 62,960 shares of Savara common stock were withheld by the company at a price of $6.92 per share to satisfy her tax liability upon vesting of previously awarded restricted stock units. After this withholding transaction, she directly beneficially owns 371,712 Savara shares.
Savara Inc. director Richard Hawkins reported an equity award of 40,000 restricted stock units (RSUs) of Savara common stock dated December 9, 2025. The RSUs vest in full on December 9, 2026, provided he continues his service with the company, and each RSU represents a right to receive one share of common stock. He has elected to defer delivery of the vested shares until after his service with Savara ends. Following this grant, he beneficially owns 161,326 shares of Savara common stock in direct ownership.
Savara Inc director David Ramsay reported the acquisition of 40,000 restricted stock units (RSUs) tied to the company’s common stock on December 9, 2025. The RSUs vest in full on December 9, 2026, provided he continues to serve with Savara, and each RSU represents a contingent right to receive one share of common stock. The transaction price was listed as $0.00, indicating no cash was paid for the award. Following this grant, Ramsay beneficially owns 2,553,642 shares of Savara common stock in direct ownership.
Savara Inc director Joseph S. McCracken reported acquiring 40,000 shares of common stock on December 9, 2025 at a reported price of $0.00 per share. Following this equity award, he beneficially owns 300,837 shares of Savara common stock directly.
The 40,000 shares are described as restricted stock units (RSUs) that vest in full on December 9, 2026, if he continues his service with the company. Each RSU represents a contingent right to receive one share of common stock, and he has elected to defer receipt of these shares so that they will be delivered after his service with Savara ends.
Savara Inc. (SVRA) director reports stock option exercise. A Savara director filed a Form 4 reporting the exercise of a stock option for 5,860 shares of common stock on 11/14/2025 at an exercise price of $1.46 per share. After this transaction, the director directly holds 121,326 shares of Savara common stock. The related stock option, which vested in twelve equal quarterly installments beginning on March 15, 2016, has now been fully exercised, leaving 0 derivative securities beneficially owned.
Savara Inc. (SVRA) Form 4: The company’s Chief Medical Officer reported equity awards on 10/20/2025. The filing shows an acquisition of 35,000 restricted stock units (RSUs) at a price of $0.00, lifting directly held common shares to 190,000 following the transaction. The RSUs vest in full on 10/17/2027, each converting into one share upon vesting.
Separately, the officer received a stock option for 70,000 shares with an exercise price of $4.11 and an expiration on 10/20/2035. This option vests in sixteen equal quarterly installments beginning 10/17/2025. These are routine compensatory awards and do not indicate open‑market buying or selling.